Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Conti

Showing results (51-60 of 345) with videos related to

Pageof 35
Sort By:
Dermatology Practical & Conceptual|December 9, 2024
Are Tattoos Safe in Patients with Systemic Lupus Erythematosus? Results From a Single-Center StudyFrancesco Natalucci, Fulvia Ceccarelli, Licia Picciariello, et al.
Rheumatology (Oxford, England)|October 9, 2024
Caffeine improves systemic lupus erythematosus endothelial dysfunction by promoting endothelial progenitor cells survivalValeria Orefice, Fulvia Ceccarelli, Cristiana Barbati, et al.
Arthritis and Rheumatism|April 9, 2005
Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximabFabrizio Conti, Roberta Priori, Maria Sole Chimenti, et al.
International Journal of Molecular Sciences|November 14, 2019
<i>Staphylococcus aureus</i> Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and PhenotypeFulvia Ceccarelli, Carlo Perricone, Giulio Olivieri, et al.
Lupus|October 3, 2022
Science and visual Arts: Binomial or Dichotomy? A Pilot study in Systemic Lupus Erythematosus patientsVincenza Ferrara, Maria Elisabetta Perrone, Concetta Mina, et al.
Japanese Journal of Ophthalmology|June 8, 2007
Infliximab treatment for ocular and extraocular manifestations of Behçet's diseaseMassimo Accorinti, Maria Pia Pirraglia, Maria Pia Paroli, et al.
Journal of the American Academy of Dermatology|August 11, 2018
Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study"Ennio Giulio Favalli, Fabrizio Conti, Fabiola Atzeni, et al.
Rheumatology International|September 24, 2025
Ultrasound clusters of joint inflammation in systemic lupus erythematosus: a cross-sectional studyFrancesco Natalucci, Fulvia Ceccarelli, Claudia Ciancarella, et al.
Cells|July 13, 2019
Mucosa-Environment Interactions in the Pathogenesis of Rheumatoid ArthritisBruno Lucchino, Francesca Romani Spinelli, Cristina Iannuccelli, et al.
Clinical and Experimental Rheumatology|May 31, 2024
Application of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patientsFulvia Ceccarelli, Licia Picciariello, Francesco Natalucci, et al.
Pageof 35

Showing results (51-60 of 345) with videos related to

Sort By:
Pageof 35
Dermatology Practical & Conceptual|December 9, 2024
Are Tattoos Safe in Patients with Systemic Lupus Erythematosus? Results From a Single-Center StudyFrancesco Natalucci, Fulvia Ceccarelli, Licia Picciariello, et al.
Rheumatology (Oxford, England)|October 9, 2024
Caffeine improves systemic lupus erythematosus endothelial dysfunction by promoting endothelial progenitor cells survivalValeria Orefice, Fulvia Ceccarelli, Cristiana Barbati, et al.
Arthritis and Rheumatism|April 9, 2005
Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximabFabrizio Conti, Roberta Priori, Maria Sole Chimenti, et al.
International Journal of Molecular Sciences|November 14, 2019
<i>Staphylococcus aureus</i> Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and PhenotypeFulvia Ceccarelli, Carlo Perricone, Giulio Olivieri, et al.
Lupus|October 3, 2022
Science and visual Arts: Binomial or Dichotomy? A Pilot study in Systemic Lupus Erythematosus patientsVincenza Ferrara, Maria Elisabetta Perrone, Concetta Mina, et al.
Japanese Journal of Ophthalmology|June 8, 2007
Infliximab treatment for ocular and extraocular manifestations of Behçet's diseaseMassimo Accorinti, Maria Pia Pirraglia, Maria Pia Paroli, et al.
Journal of the American Academy of Dermatology|August 11, 2018
Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study"Ennio Giulio Favalli, Fabrizio Conti, Fabiola Atzeni, et al.
Rheumatology International|September 24, 2025
Ultrasound clusters of joint inflammation in systemic lupus erythematosus: a cross-sectional studyFrancesco Natalucci, Fulvia Ceccarelli, Claudia Ciancarella, et al.
Cells|July 13, 2019
Mucosa-Environment Interactions in the Pathogenesis of Rheumatoid ArthritisBruno Lucchino, Francesca Romani Spinelli, Cristina Iannuccelli, et al.
Clinical and Experimental Rheumatology|May 31, 2024
Application of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patientsFulvia Ceccarelli, Licia Picciariello, Francesco Natalucci, et al.
Pageof 35